|
Comparison of pleural cancer mortality rates in countries with or without molecular genetic evidence of SV40 |
||||
| Category |
Cut-off level |
Mean pleural cancer mortality in SV40-nucleic acid positive countries (/100 000/yr) |
Mean pleural cancer mortality in SV40-nucleic acid negative countries (/100 000/yr) |
P |
|
|
||||
| Males* |
0% |
0.97 (n = 9) |
0.81 (n = 3) |
0.465 |
| Females |
0% |
0.31 (n = 9) |
0.31 (n = 3) |
0.956 |
| Males* |
10% |
1.04 (n = 8) |
0.69 (n = 4) |
0.082 |
| Females |
10% |
0.33 (n = 8) |
0.28 (n = 4) |
0.397 |
|
Cut-off level refers to the percentage of SV40-positive human tissue samples of all samples tested in a country. *Asbestos-corrected rates. | ||||
Leithner et al. Orphanet Journal of Rare Diseases 2006 1:44 doi:10.1186/1750-1172-1-44 |
||||